Skip to main content

Table 2 Reasons for treatment preference and concomitant diseases (n = 119)

From: Preference of elderly patients’ to oral or intravenous chemotherapy in heavily pre-treated recurrent ovarian cancer: final results of a prospective multicenter trial

Characteristics i.v., n = 102, (%) Oral, n = 17, (%)
Preference to therapy regime 99 (83.2) 17 (14.3)
Randomization (for indecisive patients) 3 (2.5) 0
Main reasons for therapy preference
 Wish to avoid gastrointestinal disorders 20 (19.6) 0
 Disfavour / poor toleration of oral drugs 12 (17.8) 0
 Oblivion / daily oral intake is unsure 14 (13.7) 0
 Believe i.v. application is saver over i.v. port 15 (14.7) 0
 More effective / higher treatment pressure 13 (12.3) 1 (5.9)
 Oral drug application not possible - short bowel/subileus 4 (3.9) 0
 Pre-existing chronic diarrhoea / vomiting 4 (3.9) 0
 Expect better tolerability 4 (3.9) 0
 Wish no hospital treatment / more independence / privacy 0 6 (35.3)
 The handling of the therapy is simple 0 4 (23.5)
 Continuity of the drug administration / maintenance effect 0 2 (11.8)
 Made bad experience with venous puncture 0 1 (5.9)
 Reason for preference not documented 16 (17.6) 3 (17.7)
Concomitant diseases (multiple answers)
 Cardiovascular 92 (90.2) 17 (100)
 Musculoskeletal 37 (36.3) 7 (41.2)
 Pulmonary 28 (27.5) 2 (11.8)
 Lower gastrointestinal tract 39 (38.2) 4 (23.5)
 Upper gastrointestinal tract 27 (26.5) 4 (23.5)
 Metabolic and hormonal 25 (24.5) 6 (35.3)
 Hepatic 27 (26.5) 3 (17.7)
 Renal 12 (11.8) 6 (35.3)
 Urinary tract 21 (20.6) 2 (11.8)
 Neurological 27 (26.5) 7 (41.2)
 Psychiatric 6 (5.9) 4 (23.5)